Analyst Forecast. According to 9 analysts, the average rating for PRAX stock is "Strong Buy." The month stock price forecast is $, which is an increase. Research Praxis Precision Medicines' (Nasdaq:PRAX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth. We are the first global, precision medicine clinical research organization. We incorporate laboratory expertise, clinical trial excellence, manufacturing. Find the latest analyst research, reports, and ratings for Praxis Precision Medicines, Inc. Common Stock (PRAX) at gameguruthai.ru See Precision Medicine Group funding rounds, investors, investments, exits and more. Evaluate their financials based on Precision Medicine Group's.
Praxis Precision Medicines Inc ; May, Initiated, Robert W. Baird, Outperform, $ ; Sep, Initiated, Truist, Buy, $ Based on short-term price targets offered by nine analysts, the average price target for Praxis Precision Medicines, Inc. comes to $ The forecasts range. Praxis Precision Medicines Inc PRAX:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date03/26/24 · View Praxis Precision Medicines (PRAX) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. The latest Praxis Precision Medicines stock prices, stock quotes, news, and PRAX history to help you invest and trade smarter. The Investor Relations website contains information about Praxis Precision Medicines, Inc.'s business for stockholders, potential investors, and financial. Precision Medicine Stocks List ; STOK, C, Stoke Therapeutics, Inc. ; PRAX, C, Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders. News and reporting on stock price from Precision Medicine Online Precision Oncology. Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for. Stock analysis for Praxis Precision Medicines Inc (PRAX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and.
About Praxis Precision Medicines Inc Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies. Find the latest Praxis Precision Medicines, Inc. (PRAX) stock quote, history, news and other vital information to help you with your stock trading and. Company has been rated SELL since 11/25/ The Company's Fundamentals Look Very Poor Making an Investment in Its Shares Purely Speculative. Praxis Precision Medicines (PRAX) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. On Thursday morning 08/29/ the Praxis Precision Medicines Inc Registered Shs share started trading at the price of $ Compared to the closing price on. Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for. Praxis Precision Medicines (PRAX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might. See the latest Praxis Precision Medicines Inc Ordinary Shares stock price (PRAX:XNAS), related news, valuation, dividends and more to help you make your. PRAX - Praxis Precision Medicines, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS).
Praxis Precision Medicines Treasury Stock | PRAX ; ; , $0 ; , $0 ; In the current month, PRAX has received 15 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PRAX average Analyst price target in the past 3 months is $ On further gains, the stock will meet resistance from the long-term Moving Average at $ On a fall, the stock will find some support from the short-term. Praxis Precision Medicines, Inc. stock is down % since 30 days ago. The next earnings date is Nov 5, The company has had below-average volume in the. With Praxis Precision Medicines stock trading at $ per share, the total value of Praxis Precision Medicines stock (market capitalization) is $M.
This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since it has more than doubled. Track Praxis Precision Medicines Inc (PRAX) Stock Price, Quote, latest community messages, chart, news and other stock related information.
What Is The Best Trampoline Brand | What Stocks Benefit From Rising Interest Rates